Quiz: Treatments for presbyopia coming soon

Publication
Poll
Optometry Times JournalNovember digital edition 2020
Volume 12
Issue 11

quick quiz

This quiz accompanies THIS article from our November issue

1. What is the prevalence of presbyopia in the U.S.?

a. 5,000,000
b. 10,500,000
c. 50,000,000
d. 110,000,000

2. Miotics have few side effects.

a. True
b. False

3. Which of these devices uses pinhole optics (PHO)?

Revision Raindrop
b. Karama Inlay
c. FOV Tears
d. Allergan Presbysol
e. B and D

4. Which of these is not a pharmaco-refractive product?

a. Oraisis CSF-1
b. Presbyopia Therapies PRX-100
c. Allergan AGN
d. Eyenovia Micro-dose
e. All are pharmaco-refractive

5. What is the most common ingredient in current pharmaceutical drops for presbyopia being tested?

a. Dexamethasone
b. Pilocarpine
c. Bromfenac
d. Tropicamide
e. None of the above

6. Which of these is a device?

a. Oraisis CSF-1
b. Presbyopia Therapies PRX-100
c. Allergan AGN
d. Eyenovia Micro-dose
e. FOV Tears

Which is an active ingredient in PRX-100?

a. Pilocarpine
b. Tropicamide
c. Oxymetazoline
d. Polyethylene glycol
e. Diclofenac

Click here to see the correct answers

This quiz accompanies THIS article from our November issue

Articles in this issue
Quiz: Treatments for presbyopia coming soon
Quiz: Treatments for presbyopia coming soon
Quiz Answers: Treatments for presbyopia coming soon
Quiz Answers: Treatments for presbyopia coming soon
When to lease and when to own office space
When to lease and when to own office space
Vision rehabilitation of patients with stroke
Vision rehabilitation of patients with stroke
Treatments for presbyopia coming soon
Treatments for presbyopia coming soon
How diabetes affects COVID-19
How diabetes affects COVID-19
Novel uses of technology for systemic disease
Novel uses of technology for systemic disease
Know the pros and cons of outsourcing billing
Know the pros and cons of outsourcing billing
5 communication strategies for dry eye patients
5 communication strategies for dry eye patients
2 factors that increase risk of microbial keratitis in contact lens wearers
2 factors that increase risk of microbial keratitis in contact lens wearers
Association found between laminar thinning and poor cognitive function
Association found between laminar thinning and poor cognitive function
When good retinal surgery makes glaucoma go bad
When good retinal surgery makes glaucoma go bad
Show gratitude even in 2020
Show gratitude even in 2020
Diabetic retinopathy clinical pearl pictorial
Diabetic retinopathy clinical pearl pictorial
Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Kurt Moody, OD, FAAO, describes how to fit multifocal contact lenses in a way that patients love
Tracy Lynn Schroeder Swartz O.D., M.S., FAAO, overviews her talk on comanagement
Nick Bruns, OD, FAAO, talks premium IOLs and EVO ICL at AOA 2024.
Neda Shamie, MD, details the upcoming CIME 2024 meeting
Jacob R. Lang, OD, FAAO
The ins and outs of fitting multifocal contact lenses with Dr Jessica Crooker
Related Content
2024 dice Image credit: AdobeStock/SHOHIDGraphics

Year in review: Innovations and insights in refractive optometry and vision care in 2024

Cecelia Koetting, OD, FAAO, DipABO
December 19th 2024
Article
Optometry Times You and Eye

You and Eye: Undergoing EVO ICL vision correction as an eye care professional - with Jessica Vaidya, OD

Miriam Korik, OD;Jessica Vaidya, OD;Emily Kaiser Maharjan, Assistant Managing Editor
July 31st 2024
Podcast
FDA sign Image credit: AdobeStock/TadaImages

US FDA accepts NDA for LENZ Therapeutics' LNZ100 for the treatment of presbyopia

Jordana Joy, Associate Editor
October 24th 2024
Article
Podcast: Visus presbyopia drop gets FDA IND OK

Podcast: Visus presbyopia drop gets FDA IND OK

Rhett Schiffman, MD, MHSA;Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director;Brooke Henson, Editor
April 9th 2021
Podcast
Odyssey IOL packaging Image credit: Johnson & Johnson

Johnson & Johnson announces US launch of TECNIS Odyssey IOL

Martin David Harp, Associate Editor, Ophthalmology Times
October 4th 2024
Article
Eye drop being administered to petri dish Image credit: AdobeStock/ValeriLuzina

Results released from Ocuphire Pharma of MIRA-2 and MIRA-3 clinical trials for phentolamine ophthalmic solution 0.75% for pharmacologically-induced mydriasis

David Hutton, Managing Editor, Ophthalmology Times
October 4th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.